← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2013Last known activity
Mar 3, 2023
Timeline
2000s
- Dec 1, 2007
Kineta Inc.— Founded
2020s
- Dec 19, 2022
Yumanity— Acquired
Drugs by trial phase (9 distinct, 11 trials)
Phase 2 (2 own, 1 via acquisition)
Phase 1 (2 own, 4 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (7)
- NCT05708950Lead sponsorPhase 1/Phase 2Mar 3, 2023
- NCT05708950Study directorPhase 1/Phase 2Mar 3, 2023
- NCT03993704Lead sponsorPhase 1Jul 31, 2019
- NCT02435342Lead sponsorPhase 1Oct 1, 2014
- NCT02435342Study directorPhase 1Oct 1, 2014
- NCT02446340Lead sponsorPhase 1Nov 1, 2013
- NCT02446340Study chairPhase 1Nov 1, 2013
Details
- Founded
- Seattle, WA, US Dec 1, 2007
- Last known activity
- Mar 3, 2023